SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-016142
Filing Date
2022-08-09
Accepted
2022-08-09 16:53:55
Documents
105
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q orgo-20220630.htm   iXBRL 10-Q 3332646
2 EX-10.1 orgo-ex10_1.htm EX-10.1 167651
3 EX-31.1 orgo-ex31_1.htm EX-31.1 19266
4 EX-31.2 orgo-ex31_2.htm EX-31.2 19757
5 EX-32.1 orgo-ex32_1.htm EX-32.1 21673
  Complete submission text file 0000950170-22-016142.txt   14134458

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT orgo-20220630.xsd EX-101.SCH 75455
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT orgo-20220630_cal.xml EX-101.CAL 64214
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT orgo-20220630_pre.xml EX-101.PRE 489527
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT orgo-20220630_lab.xml EX-101.LAB 533589
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT orgo-20220630_def.xml EX-101.DEF 340017
99 EXTRACTED XBRL INSTANCE DOCUMENT orgo-20220630_htm.xml XML 3346819
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Filer) CIK: 0001661181 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37906 | Film No.: 221149166
SIC: 2834 Pharmaceutical Preparations